What follows is a guest blog post from the psychedelic integration volunteer mentioned in the previous blog post.
As James said in his post, ingestion of psychedelics under supervision in a safe setting greatly increases the likelihood that the psychedelic experience is one of therapeutic benefit.
I completely agree, however the safe setting that I chose could be regarded by many as highly unsafe. The middle of the Peruvian jungle, in an off grid camp, next to a tributary of the Amazon river, a day's canoe ride from any medical help. It's tough to find somewhere to do it in the UK. I'm an adventurer so it wasn't too much of an issue for me. I was highly motivated by the desire to rid myself of the heavy darkness I was carrying inside me, I didn't want it but I couldn't seem to free myself from it. I'd made progress through counseling, meditation, yoga, NVC (non violent communication), spiritual teachers on youtube and various other weird and wonderful retreats I'd attended. But something was still there and I couldn't get to it. They name this plant medicine "The Mother" in the Amazon, and they say it calls you. When I learned about Ayahuasca, it called me.
There is an emerging paradigm shift taking hold in the treatment of mental illness. It goes by the name of Psychedelic Assisted Psychotherapy, and essentially involves the ingestion of psychedelics under supervision in a safe setting. Doing so greatly increases the likelihood that the psychedelic experience is one of therapeutic benefit.
Such benefits include the treatment of treatment-resistant depression, fear of death in terminal cancer patients and nicotine addiction. The results from research done so far is very compelling - some cases of which show that three doses can have lasting and sustained positive outcomes, such as an 80% success rate in the case of treating nicotine addiction. And, indeed, that one dose can make a beneficial and lasting impact on those suffering from depression. Such success rates are totally unheard of in the existing paradigm. Similarly impressive results are seen in the treatment of post traumatic stress disorder (PTSD). With two new research centres now established - one in Imperial College London and the other at John Hopkins University - many more studies are planned.